医学
皮肤病科
流行病学
皮肤癌
癌症
病理
内科学
作者
Samir Salah,Delphine Kérob,Khaled Ezzedine,Puneet Khurana,Deepthi Balan,Thierry Passeron
摘要
Dear Editor, Skin cancer represents a significant health burden, with rising incidence worldwide.1 We analysed melanoma and nonmelanoma skin cancer rates across 185 countries, examining the relationship with dermatologist density to understand healthcare system effectiveness.The International Agency for Research on Cancer (IARC) GLOBOCAN 2022 estimates provided data for melanoma (ICD-10 code C43) and nonmelanoma skin cancer (NMSC, ICD-10 code C44), with NMSC incidence excluding basal cell carcinoma while mortality includes it.2 CDC data contributed melanoma incidence by ethnicity in the United States.3 Agestandardized rates per 100,000 person-years were calculated using the World standard population, accounting for varying population age structures.4 Dermatologist density data was sourced from an unpublished L'Oreal survey covering 31 countries, with density calculated per 100,000 population.5 This survey compiled information from official registries, publications and professional associations.5 In 2022, there were 331,722 estimated melanoma cases (58,667 deaths) and 1.2 million NMSC cases (69,416 deaths) globally.The highest age-standardized incidence rates (ASR) for melanoma were found in Oceania (29.78/100,000),North America (16.3) and Europe (10.43).Notably,
科研通智能强力驱动
Strongly Powered by AbleSci AI